MedPath

Hematological and biochemical markers as poor outcome predictors in COVID-19

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B999- Unspecified infectious disease
Registration Number
CTRI/2020/12/029897
Lead Sponsor
Pramukh Swami Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients admitted in our hospital from March 2020 till date and positive for RAT and RTPCR for COVID-19 will be included irrespective of the outcome

Exclusion Criteria

Patients less than 18 years of age will be excluded

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study will help us in understanding the physio-pathology of the disease in a better way. There may <br/ ><br>be a chance that a better triage of patients with bad predictive markers will help us treat and manage them in <br/ ><br>a different way. It will make counseling the patientâ??s relatives regarding the late complications of <br/ ><br>COVID . We may be able to introduce newer dimensions to our <br/ ><br>existing SOPs. In the long run, this will help the institution save lots of money and time.Timepoint: The data will be assessed after every 100 subjects are taken and then once 1000 sample size is reached. probably after 8 weeks
Secondary Outcome Measures
NameTimeMethod
We propose to incorporate newer modifications in existing SOP <br/ ><br>publicationTimepoint: within 1 year
© Copyright 2025. All Rights Reserved by MedPath